Consolidated management report as of 31 December 2024
Notes to the consolidated financial report as of 31 December 2024
Consolidated financial report according to IFRS as of 31 December 2024
Sales revenues for January 2025
Sofia, Bulgaria, February 20, 2025 – According to the requirements of Art. 100t of the Law on Public Offering of Securities (LPOS), “Sopharma” AD (SFA: “Bulgarian Stock Exchange” AD, SPH: Warsaw Stock Exchange) notifies, that for January 2025 the Company recorded an increase in sales of 7% compared to the same month of the previous year, incl. 6% increase in domestic sales and 8% increase in export sales.
Notification for a significant shareholding from CUPF Alianz Bulgaria
Sofia, Bulgaria, January 31, 2025 – According to the requirements of Art. 100t of LPOS, “Sopharma” AD (SFA: “Bulgarian Stock Exchange AD, SPH: Warsaw Stock Exchange) notifies that today the Company received a notification for significant shareholding from CUPF Alianz Bulgaria.
Individual financial results for the fourth quarter of 2024
Declaration by the responsible directors as of 31 December 2024
Information according to Annex 4 of Ordinance 2 as of 31 December 2024
Individual financial report according to BFSC standards as of 31 December 2024
Strony
- « pierwsza
- ‹ poprzednia
- 1
- 2
- 3
- 4
- 5
- 6
- 7
- 8
- 9
- …
- następna ›
- ostatnia »